Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions.

Multiple sclerosis is a chronic inflammatory, demyelinating disease, although it has been suggested that in the progressive late phase, inflammatory lesion activity declines. We recently showed in the Netherlands Brain Bank multiple sclerosis-autopsy cohort considerable ongoing inflammatory lesion activity also at the end stage of the disease, based on microglia/macrophage activity. We have now studied the role of T cells in this ongoing inflammatory lesion activity in chronic multiple sclerosis autopsy cases. We quantified T cells and perivascular T-cell cuffing at a standardized location in the medulla oblongata in 146 multiple sclerosis, 20 neurodegenerative control and 20 non-neurological control brain donors. In addition, we quantified CD3+, CD4+, and CD8+ T cells in 140 subcortical white matter lesions. The location of CD8+ T cells in either the perivascular space or the brain parenchyma was determined using CD8/laminin staining and confocal imaging. Finally, we analysed CD8+ T cells, isolated from fresh autopsy tissues from subcortical multiple sclerosis white matter lesions (n = 8), multiple sclerosis normal-appearing white matter (n = 7), and control white matter (n = 10), by flow cytometry. In normal-appearing white matter, the number of T cells was increased compared to control white matter. In active and mixed active/inactive lesions, the number of T cells was further augmented compared to normal-appearing white matter. Active and mixed active/inactive lesions were enriched for both CD4+ and CD8+ T cells, the latter being more abundant in all lesion types. Perivascular clustering of T cells in the medulla oblongata was only found in cases with a progressive disease course and correlated with a higher percentage of mixed active/inactive lesions and a higher lesion load compared to cases without perivascular clusters in the medulla oblongata. In all white matter samples, CD8+ T cells were located mostly in the perivascular space, whereas in mixed active/inactive lesions, 16.3% of the CD8+ T cells were encountered in the brain parenchyma. CD8+ T cells from mixed active/inactive lesions showed a tissue-resident memory phenotype with expression of CD69, CD103, CD44, CD49a, and PD-1 and absence of S1P1. They upregulated markers for homing (CXCR6), reactivation (Ki-67), and cytotoxicity (GPR56), yet lacked the cytolytic enzyme granzyme B. These data show that in chronic progressive multiple sclerosis cases, inflammatory lesion activity and demyelinated lesion load is associated with an increased number of T cells clustering in the perivascular space. Inflammatory active multiple sclerosis lesions are populated by CD8+ tissue-resident memory T cells, which show signs of reactivation and infiltration of the brain parenchyma.

[1]  J. Goverman,et al.  Myelin-specific CD8 T cells exacerbate brain inflammation in CNS autoimmunity. , 2019, The Journal of clinical investigation.

[2]  E. Remmerswaal,et al.  Post‐mortem multiple sclerosis lesion pathology is influenced by single nucleotide polymorphisms , 2019, Brain pathology.

[3]  G. D. Di Liberto,et al.  Brain-resident memory T cells generated early in life predispose to autoimmune disease in mice , 2019, Science Translational Medicine.

[4]  H. Lassmann,et al.  Communication of CD8+ T cells with mononuclear phagocytes in multiple sclerosis , 2019, Annals of clinical and translational neurology.

[5]  Shwetank,et al.  PD-1 Dynamically Regulates Inflammation and Development of Brain-Resident Memory CD8 T Cells During Persistent Viral Encephalitis , 2019, Front. Immunol..

[6]  D. Farber,et al.  Location, location, location: Tissue resident memory T cells in mice and humans , 2019, Science Immunology.

[7]  T. Ulas,et al.  Transcriptional profiling of human microglia reveals grey–white matter heterogeneity and multiple sclerosis-associated changes , 2019, Nature Communications.

[8]  J. Christensen,et al.  Local Antigen Encounter Is Essential for Establishing Persistent CD8+ T-Cell Memory in the CNS , 2019, Front. Immunol..

[9]  I. Coutinho,et al.  Demyelinating disease of the central nervous system associated with Pembrolizumab treatment for metastatic melanoma , 2018, Multiple sclerosis.

[10]  E. Remmerswaal,et al.  Tissue-resident memory T cells populate the human brain , 2018, Nature Communications.

[11]  H. Lassmann,et al.  The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells , 2018, Brain : a journal of neurology.

[12]  O. Ciccarelli,et al.  Multiple sclerosis , 2018, The Lancet.

[13]  D. Topham,et al.  Tissue-Resident Memory CD8+ T Cells: From Phenotype to Function , 2018, Front. Immunol..

[14]  M. Macleod,et al.  The roles of resident, central and effector memory CD4 T‐cells in protective immunity following infection or vaccination , 2018, Immunology.

[15]  M. Bevan,et al.  Dynamics of Tissue-Specific CD8+ T Cell Responses during West Nile Virus Infection , 2018, Journal of Virology.

[16]  C. V. van Eden,et al.  Progressive multiple sclerosis patients show substantial lesion activity that correlates with clinical disease severity and sex: a retrospective autopsy cohort analysis , 2018, Acta Neuropathologica.

[17]  R. Nitsch,et al.  Extravascular CD3+ T Cells in Brains of Alzheimer Disease Patients Correlate with Tau but Not with Amyloid Pathology: An Immunohistochemical Study , 2018, Neurodegenerative Diseases.

[18]  E. Hol,et al.  Gene Expression Profiling of Multiple Sclerosis Pathology Identifies Early Patterns of Demyelination Surrounding Chronic Active Lesions , 2017, Front. Immunol..

[19]  Elmar Eisemann,et al.  Visual analysis of mass cytometry data by hierarchical stochastic neighbour embedding reveals rare cell types , 2017, Nature Communications.

[20]  J. Paul Robinson,et al.  Guidelines for the use of flow cytometry and cell sorting in immunological studies. , 2017, European journal of immunology.

[21]  Yufeng Shen,et al.  Human Tissue-Resident Memory T Cells Are Defined by Core Transcriptional and Functional Signatures in Lymphoid and Mucosal Sites. , 2017, Cell reports.

[22]  A. Langerak,et al.  Phenotypic and functional characterization of T cells in white matter lesions of multiple sclerosis patients , 2017, Acta Neuropathologica.

[23]  K. Schuurman,et al.  Isolation of primary microglia from the human post-mortem brain: effects of ante- and post-mortem variables , 2017, Acta neuropathologica communications.

[24]  C. Pitzalis,et al.  Ectopic Lymphoid Structures: Powerhouse of Autoimmunity , 2016, Front. Immunol..

[25]  A. Louveau,et al.  Lymphatics in Neurological Disorders: A Neuro-Lympho-Vascular Component of Multiple Sclerosis and Alzheimer’s Disease? , 2016, Neuron.

[26]  B. Weinshenker,et al.  Disease modifying therapies for relapsing multiple sclerosis , 2016, British Medical Journal.

[27]  E. Remmerswaal,et al.  The Adhesion G Protein-Coupled Receptor GPR56/ADGRG1 Is an Inhibitory Receptor on Human NK Cells. , 2016, Cell reports.

[28]  R. Verwer,et al.  MicroRNA-132 and early growth response-1 in nucleus basalis of Meynert during the course of Alzheimer's disease. , 2016, Brain : a journal of neurology.

[29]  W. Brück,et al.  The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain , 2016, Brain : a journal of neurology.

[30]  Scott N. Mueller,et al.  Tissue-resident memory T cells: local specialists in immune defence , 2015, Nature Reviews Immunology.

[31]  T. Kiehl,et al.  Subacute CNS Demyelination after Treatment with Nivolumab for Melanoma , 2015, Cancer Immunology Research.

[32]  Manuel A. Friese,et al.  Immunopathology of multiple sclerosis , 2015, Nature Reviews Immunology.

[33]  Timothy J Keyes,et al.  Structural and functional features of central nervous system lymphatics , 2015, Nature.

[34]  B. Igyártó,et al.  Quantifying Memory CD8 T Cells Reveals Regionalization of Immunosurveillance , 2015, Cell.

[35]  B. Trapp,et al.  Pathological mechanisms in progressive multiple sclerosis , 2015, The Lancet Neurology.

[36]  U. Boschert,et al.  Immunohistochemical detection of sphingosine‐1‐phosphate receptor 1 and 5 in human multiple sclerosis lesions , 2014, Neuropathology and applied neurobiology.

[37]  C. Holmes,et al.  Inflammatory components in human Alzheimer's disease and after active amyloid-β42 immunization. , 2013, Brain : a journal of neurology.

[38]  E. Remmerswaal,et al.  Characteristics of differentiated CD8+ and CD4+ T cells present in the human brain , 2013, Acta Neuropathologica.

[39]  C. V. van Eden,et al.  Selective upregulation of scavenger receptors in and around demyelinating areas in multiple sclerosis. , 2013, Journal of neuropathology and experimental neurology.

[40]  G. Smyth,et al.  The Molecular Signature of Tissue Resident Memory CD8 T Cells Isolated from the Brain , 2012, The Journal of Immunology.

[41]  L. Fugger,et al.  Bridging the gap from genetic association to functional understanding: the next generation of mouse models of multiple sclerosis , 2012, Immunological reviews.

[42]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[43]  G. Dorn,et al.  GRK2-Dependent S1PR1 Desensitization Is Required for Lymphocytes to Overcome Their Attraction to Blood , 2011, Science.

[44]  T. Scriba,et al.  Novel application of Ki67 to quantify antigen-specific in vitro lymphoproliferation , 2010, Journal of immunological methods.

[45]  M. Bevan,et al.  Memory T cells persisting within the brain after local infection show functional adaptations to their tissue of residence , 2010, Proceedings of the National Academy of Sciences.

[46]  L. Sorokin The impact of the extracellular matrix on inflammation , 2010, Nature Reviews Immunology.

[47]  D. Verzijl,et al.  Sphingosine 1‐phosphate receptor 1 and 3 are upregulated in multiple sclerosis lesions , 2010, Glia.

[48]  Hans Lassmann,et al.  The relation between inflammation and neurodegeneration in multiple sclerosis brains , 2009, Brain : a journal of neurology.

[49]  T. Vollmer,et al.  The natural history of relapses in multiple sclerosis , 2007, Journal of the Neurological Sciences.

[50]  L. Bö,et al.  Basement Membrane Proteins in Multiple Sclerosis-Associated Inflammatory Cuffs: Potential Role in Influx and Transport of Leukocytes , 2005, Journal of neuropathology and experimental neurology.

[51]  B. Serafini,et al.  Detection of Ectopic B‐cell Follicles with Germinal Centers in the Meninges of Patients with Secondary Progressive Multiple Sclerosis , 2004, Brain pathology.

[52]  Hans Lassmann,et al.  Clonal Expansions of Cd8+ T Cells Dominate the T Cell Infiltrate in Active Multiple Sclerosis Lesions as Shown by Micromanipulation and Single Cell Polymerase Chain Reaction , 2000, The Journal of experimental medicine.

[53]  Jakob S. Jensen,et al.  Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. , 1999, The Journal of clinical investigation.

[54]  J. Antel,et al.  Multiple Sclerosis: Fas Signaling in Oligodendrocyte Cell Death , 1996, The Journal of experimental medicine.

[55]  J A Frank,et al.  MRI studies of multiple sclerosis: Implications for the natural history of the disease and for monitoring effectiveness of experimental therapies , 1996, Multiple sclerosis.

[56]  A J Thompson,et al.  A comparison of the pathology of primary and secondary progressive multiple sclerosis. , 1994, Brain : a journal of neurology.

[57]  E. Elson,et al.  Retention of leukocytes in capillaries: role of cell size and deformability. , 1990, Journal of applied physiology.

[58]  M. Merkenschlager,et al.  Memory T cells , 1989, Nature.

[59]  C. Morimoto,et al.  Dual‐label immunocytochemistry of the active multiple sclerosis lesion: Major histocompatibility complex and activation antigens , 1988, Annals of neurology.

[60]  M. Esiri,et al.  Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis , 1983, Journal of the Neurological Sciences.

[61]  Prineas Jw,et al.  Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis. , 1978 .

[62]  J. Prineas,et al.  Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis. , 1978, Laboratory investigation; a journal of technical methods and pathology.

[63]  H. Koprowski,et al.  Ultrastructural studies of perivascular cuffing cells in multiple sclerosis brain. , 1975, The American journal of pathology.

[64]  John Prineas Paramyxovirus-Like Particles Associated with Acute Demyelination in Chronic Relapsing Multiple Sclerosis , 1972, Science.

[65]  W. L. Benedict,et al.  Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.